Australia markets closed

PMV Pharmaceuticals, Inc. (PMVP)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.6900+0.0400 (+2.42%)
At close: 04:00PM EDT
1.6793 -0.01 (-0.63%)
After hours: 06:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 86.94M
Enterprise value -97.98M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.41
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.52
52-week change 3-74.16%
S&P500 52-week change 318.96%
52-week high 39.7200
52-week low 31.1750
50-day moving average 31.7247
200-day moving average 31.9374

Share statistics

Avg vol (3-month) 3489.98k
Avg vol (10-day) 3252.55k
Shares outstanding 551.44M
Implied shares outstanding 651.44M
Float 840.51M
% held by insiders 12.61%
% held by institutions 192.60%
Shares short (15 July 2024) 41.16M
Short ratio (15 July 2024) 41.94
Short % of float (15 July 2024) 42.65%
Short % of shares outstanding (15 July 2024) 42.26%
Shares short (prior month 14 June 2024) 42.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-19.41%
Return on equity (ttm)-29.40%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -74.75M
Net income avi to common (ttm)-65.1M
Diluted EPS (ttm)-1.3200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)197.94M
Total cash per share (mrq)3.85
Total debt (mrq)13.02M
Total debt/equity (mrq)6.12%
Current ratio (mrq)16.79
Book value per share (mrq)4.13

Cash flow statement

Operating cash flow (ttm)-56.83M
Levered free cash flow (ttm)-35.33M